nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—artery—atherosclerosis	0.0364	0.18	CbGeAlD
Ingenol Mebutate—PRKCA—endothelium—atherosclerosis	0.0307	0.152	CbGeAlD
Ingenol Mebutate—PRKCA—blood vessel—atherosclerosis	0.0283	0.14	CbGeAlD
Ingenol Mebutate—PRKCD—connective tissue—atherosclerosis	0.0264	0.13	CbGeAlD
Ingenol Mebutate—PRKCD—adipose tissue—atherosclerosis	0.0202	0.0999	CbGeAlD
Ingenol Mebutate—PRKCA—connective tissue—atherosclerosis	0.0145	0.0718	CbGeAlD
Ingenol Mebutate—PRKCD—liver—atherosclerosis	0.0142	0.0701	CbGeAlD
Ingenol Mebutate—PRKCA—cardiovascular system—atherosclerosis	0.0126	0.0625	CbGeAlD
Ingenol Mebutate—PRKCA—adipose tissue—atherosclerosis	0.0111	0.0551	CbGeAlD
Ingenol Mebutate—PRKCA—liver—atherosclerosis	0.00782	0.0386	CbGeAlD
Ingenol Mebutate—PRKCD—Signaling Pathways—PLG—atherosclerosis	0.000148	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—TGFB1—atherosclerosis	0.000148	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—APOA1—atherosclerosis	0.000148	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AGTR1—atherosclerosis	0.000148	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD40—atherosclerosis	0.000148	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TLR2—atherosclerosis	0.000148	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IGF1—atherosclerosis	0.000147	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CYBA—atherosclerosis	0.000146	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ESR2—atherosclerosis	0.000146	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—MAPK3—atherosclerosis	0.000143	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PARP1—atherosclerosis	0.000143	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—MAPK3—atherosclerosis	0.000142	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CX3CR1—atherosclerosis	0.000142	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASR—atherosclerosis	0.000142	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—AKT1—atherosclerosis	0.000142	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—AKT1—atherosclerosis	0.000142	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NAMPT—atherosclerosis	0.000142	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—LIPC—atherosclerosis	0.000141	0.000177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—AKT1—atherosclerosis	0.000141	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PPARG—atherosclerosis	0.000141	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SOCS3—atherosclerosis	0.000141	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOC3—atherosclerosis	0.00014	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCA—M Phase—MAPK3—atherosclerosis	0.00014	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS2—atherosclerosis	0.00014	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SERPINE1—atherosclerosis	0.00014	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CX3CL1—atherosclerosis	0.00014	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—AKT1—atherosclerosis	0.000139	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—ALB—atherosclerosis	0.000139	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—LDLR—atherosclerosis	0.000139	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—AKT1—atherosclerosis	0.000139	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—EDN1—atherosclerosis	0.000138	0.000173	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CCL5—atherosclerosis	0.000137	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—atherosclerosis	0.000136	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CETP—atherosclerosis	0.000136	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP3—atherosclerosis	0.000136	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF2—atherosclerosis	0.000135	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000134	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD14—atherosclerosis	0.000133	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS3—atherosclerosis	0.000133	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CNR2—atherosclerosis	0.000132	0.000166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—MMP3—atherosclerosis	0.000132	0.000165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000132	0.000165	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOB—atherosclerosis	0.000131	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PRKCG—atherosclerosis	0.00013	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SCARB1—atherosclerosis	0.00013	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CXCL8—atherosclerosis	0.00013	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EDN1—atherosclerosis	0.000129	0.000162	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—VCAM1—atherosclerosis	0.000129	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—MAPK3—atherosclerosis	0.000128	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL5—atherosclerosis	0.000128	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—INS—atherosclerosis	0.000128	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—SERPINE1—atherosclerosis	0.000127	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—atherosclerosis	0.000126	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EDN1—atherosclerosis	0.000126	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—LPL—atherosclerosis	0.000125	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SOCS3—atherosclerosis	0.000125	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL5—atherosclerosis	0.000125	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HMGCR—atherosclerosis	0.000123	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PRKCG—atherosclerosis	0.000122	0.000153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of mRNA—AKT1—atherosclerosis	0.00012	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.000119	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SPP1—atherosclerosis	0.000119	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PRKCG—atherosclerosis	0.000118	0.000148	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CXCL8—atherosclerosis	0.000118	0.000148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VWF—atherosclerosis	0.000118	0.000148	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SERPINE1—atherosclerosis	0.000118	0.000148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SIRT1—atherosclerosis	0.000118	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOC3—atherosclerosis	0.000117	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LDLR—atherosclerosis	0.000116	0.000146	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IFNG—atherosclerosis	0.000116	0.000146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AGT—atherosclerosis	0.000115	0.000144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL18—atherosclerosis	0.000114	0.000143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL3—atherosclerosis	0.000114	0.000143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD40LG—atherosclerosis	0.000113	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS3—atherosclerosis	0.000112	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PDGFB—atherosclerosis	0.00011	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ABCA1—atherosclerosis	0.00011	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AGER—atherosclerosis	0.000109	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NCF1—atherosclerosis	0.000109	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PRKCG—atherosclerosis	0.000108	0.000136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOB—atherosclerosis	0.000108	0.000135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AGT—atherosclerosis	0.000107	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT1—atherosclerosis	0.000107	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—F2—atherosclerosis	0.000106	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD36—atherosclerosis	0.000106	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—LEP—atherosclerosis	0.000105	0.000132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOE—atherosclerosis	0.000105	0.000132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—atherosclerosis	0.000105	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AGT—atherosclerosis	0.000104	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—atherosclerosis	0.000104	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CAV1—atherosclerosis	0.000104	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOA1—atherosclerosis	0.000104	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL1B—atherosclerosis	0.000104	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCR2—atherosclerosis	0.000103	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EDNRA—atherosclerosis	0.000103	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—LPL—atherosclerosis	0.000103	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—atherosclerosis	0.000103	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AKT1—atherosclerosis	0.000102	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CYBA—atherosclerosis	0.000102	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000101	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GHRL—atherosclerosis	0.0001	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PARP1—atherosclerosis	0.0001	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PLAT—atherosclerosis	0.0001	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ESR1—atherosclerosis	0.0001	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PRKCG—atherosclerosis	9.99e-05	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—F2—atherosclerosis	9.9e-05	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARA—atherosclerosis	9.77e-05	0.000123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PDGFB—atherosclerosis	9.75e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT1—atherosclerosis	9.67e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NFKB1—atherosclerosis	9.66e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—F2—atherosclerosis	9.63e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—atherosclerosis	9.6e-05	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—atherosclerosis	9.6e-05	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MAPK3—atherosclerosis	9.59e-05	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CRP—atherosclerosis	9.53e-05	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NFKB1—atherosclerosis	9.52e-05	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MAPK8—atherosclerosis	9.49e-05	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CG—atherosclerosis	9.48e-05	0.000119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HMOX1—atherosclerosis	9.41e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MAPK8—atherosclerosis	9.36e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTHFR—atherosclerosis	9.25e-05	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CG—atherosclerosis	9.21e-05	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TLR4—atherosclerosis	9.14e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—MAPK3—atherosclerosis	9.08e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—MAPK3—atherosclerosis	9.08e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOB—atherosclerosis	9.01e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PDGFB—atherosclerosis	9e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—INS—atherosclerosis	8.97e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—atherosclerosis	8.91e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ESR1—atherosclerosis	8.86e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL2—atherosclerosis	8.83e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB1—atherosclerosis	8.81e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KNG1—atherosclerosis	8.8e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTM1—atherosclerosis	8.77e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ICAM1—atherosclerosis	8.76e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AGTR1—atherosclerosis	8.75e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT3—atherosclerosis	8.68e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1—atherosclerosis	8.68e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOE—atherosclerosis	8.61e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—LPL—atherosclerosis	8.6e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL2—atherosclerosis	8.58e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MAPK3—atherosclerosis	8.57e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CAV1—atherosclerosis	8.53e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PLG—atherosclerosis	8.52e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOA1—atherosclerosis	8.51e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GPX1—atherosclerosis	8.39e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MAPK3—atherosclerosis	8.29e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MAPK3—atherosclerosis	8.25e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SERPINE1—atherosclerosis	8.24e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MAPK3—atherosclerosis	8.18e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CD36—atherosclerosis	8.18e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—atherosclerosis	8.08e-05	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SOCS3—atherosclerosis	8.07e-05	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS2—atherosclerosis	8.02e-05	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—STAT3—atherosclerosis	8.01e-05	0.0001	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOS3—atherosclerosis	7.87e-05	9.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP3—atherosclerosis	7.8e-05	9.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF2—atherosclerosis	7.76e-05	9.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTHFR—atherosclerosis	7.75e-05	9.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MAPK3—atherosclerosis	7.66e-05	9.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARA—atherosclerosis	7.6e-05	9.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOB—atherosclerosis	7.53e-05	9.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCL8—atherosclerosis	7.47e-05	9.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFB1—atherosclerosis	7.43e-05	9.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EDN1—atherosclerosis	7.42e-05	9.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AGT—atherosclerosis	7.36e-05	9.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL5—atherosclerosis	7.36e-05	9.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—INS—atherosclerosis	7.36e-05	9.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SERPINE1—atherosclerosis	7.28e-05	9.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOE—atherosclerosis	7.21e-05	9.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LPL—atherosclerosis	7.19e-05	9.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CAV1—atherosclerosis	7.15e-05	8.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOA1—atherosclerosis	7.13e-05	8.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKCG—atherosclerosis	7e-05	8.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL8—atherosclerosis	6.98e-05	8.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SPP1—atherosclerosis	6.81e-05	8.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL8—atherosclerosis	6.78e-05	8.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SERPINE1—atherosclerosis	6.76e-05	8.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—atherosclerosis	6.74e-05	8.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFNG—atherosclerosis	6.67e-05	8.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—atherosclerosis	6.64e-05	8.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CG—atherosclerosis	6.51e-05	8.16e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS3—atherosclerosis	6.45e-05	8.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—atherosclerosis	6.31e-05	7.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PDGFB—atherosclerosis	6.3e-05	7.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—atherosclerosis	6.28e-05	7.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NFKB1—atherosclerosis	6.24e-05	7.83e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—INS—atherosclerosis	6.16e-05	7.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AGT—atherosclerosis	6.15e-05	7.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK8—atherosclerosis	6.14e-05	7.69e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—atherosclerosis	6.13e-05	7.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—atherosclerosis	6.12e-05	7.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—atherosclerosis	6.06e-05	7.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—LEP—atherosclerosis	6.03e-05	7.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOE—atherosclerosis	6.03e-05	7.56e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—atherosclerosis	5.98e-05	7.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CAV1—atherosclerosis	5.98e-05	7.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOA1—atherosclerosis	5.96e-05	7.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL1B—atherosclerosis	5.95e-05	7.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—atherosclerosis	5.9e-05	7.4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ESR1—atherosclerosis	5.76e-05	7.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—F2—atherosclerosis	5.69e-05	7.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—atherosclerosis	5.67e-05	7.1e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALB—atherosclerosis	5.65e-05	7.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT3—atherosclerosis	5.61e-05	7.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—atherosclerosis	5.6e-05	7.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—atherosclerosis	5.59e-05	7.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—atherosclerosis	5.56e-05	6.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NFKB1—atherosclerosis	5.55e-05	6.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—atherosclerosis	5.52e-05	6.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK8—atherosclerosis	5.45e-05	6.84e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CG—atherosclerosis	5.44e-05	6.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NOS3—atherosclerosis	5.4e-05	6.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK3—atherosclerosis	5.36e-05	6.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—MAPK3—atherosclerosis	5.21e-05	6.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFB1—atherosclerosis	5.2e-05	6.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—atherosclerosis	5.16e-05	6.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—INS—atherosclerosis	5.15e-05	6.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL2—atherosclerosis	5.07e-05	6.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT3—atherosclerosis	4.98e-05	6.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1—atherosclerosis	4.98e-05	6.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—atherosclerosis	4.94e-05	6.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK3—atherosclerosis	4.76e-05	5.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MAPK3—atherosclerosis	4.74e-05	5.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SERPINE1—atherosclerosis	4.73e-05	5.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—STAT3—atherosclerosis	4.6e-05	5.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOS3—atherosclerosis	4.52e-05	5.66e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MAPK3—atherosclerosis	4.4e-05	5.51e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFB1—atherosclerosis	4.27e-05	5.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL8—atherosclerosis	4.01e-05	5.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—atherosclerosis	3.92e-05	4.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—atherosclerosis	3.87e-05	4.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—atherosclerosis	3.81e-05	4.78e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—atherosclerosis	3.62e-05	4.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—atherosclerosis	3.62e-05	4.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NFKB1—atherosclerosis	3.59e-05	4.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK8—atherosclerosis	3.53e-05	4.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—atherosclerosis	3.52e-05	4.41e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—atherosclerosis	3.48e-05	4.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—atherosclerosis	3.25e-05	4.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT3—atherosclerosis	3.22e-05	4.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—atherosclerosis	3.21e-05	4.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—atherosclerosis	3.21e-05	4.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—atherosclerosis	3.19e-05	4e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK3—atherosclerosis	3.08e-05	3.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFB1—atherosclerosis	2.99e-05	3.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—atherosclerosis	2.97e-05	3.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—atherosclerosis	2.48e-05	3.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—atherosclerosis	2.25e-05	2.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—atherosclerosis	2.08e-05	2.6e-05	CbGpPWpGaD
